Giant Cell Tumor of Bone (GCTB) is a common intermediate tumor, and the specific molecular mechanisms of this disease have not been fully elucidated. It exhibits strong heterogeneity in terms of targets, regulatory mechanisms, cell types, states, and subset distributions in the immune microenvironment. Traditional collective-level analyses cannot accurately reveal these differences. Single-cell sequencing technology is a technique that sequences the genome, transcriptome, and epigenome of diseases at the single-cell level. Single-cell sequencing can utilize a higher pixel resolution to reveal characteristic states of different cell subpopulations, contributing to broadening new perspectives for the study of GCTB heterogeneity. It holds significant value for the precise diagnosis of GCTB, identification of potential immunotherapy targets, and prognosis assessment. This study primarily reviews research related to GCTB, single-cell high-throughput sequencing technology, GCTB immune microenvironment, GCTB heterogeneity, and the construction of GCTB cell maps. It aims to provide theoretical reference for research on single-cell sequencing technology in GCTB and offers a theoretical basis for in-depth exploration of the mechanisms and treatment of GCTB.
| Published in | Cancer Research Journal (Volume 12, Issue 1) |
| DOI | 10.11648/j.crj.20241201.12 |
| Page(s) | 5-9 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Giant Cell Tumor of Bone, Single-Cell Sequencing, Tumor Microenvironment, Heterogeneity
| [1] | Niu X, Zhang Q, Hao L, et al. Giant Cell Tumor of the Extremity: Retrospective Analysis of 621 Chinese Patients from One Institution. Journal of Bone and Joint Surgery. 2012; 94(5): 461-467. doi: 10.2106/JBJS.J.01922. |
| [2] | Lipplaa A, Dijkstra S, Gelderblom H. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone. Current Opinion in Oncology. 2019; 31(4): 329-335. doi: 10.1097/CCO.0000000000000529. |
| [3] | van der Heijden L, Dijkstra PDS, van de Sande MAJ, et al. The clinical approach toward giant cell tumor of bone. Oncologist. 2014; 19(5): 550-561. doi: 10.1634/theoncologist.2013-0432. |
| [4] | Lee JC, Liang CW, Fletcher CD. Giant cell tumor of soft tissue is genetically distinct from its bone counterpart. Modern Pathology. 2017; 30(5): 728-733. doi: 10.1038/modpathol.2016.236. |
| [5] | Wülling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumor of bone. Journal of Cancer Research and Clinical Oncology. 2001; 127(8): 467-474. doi: 10.1007/s004320100234. |
| [6] | Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ. Giant Cell Tumor of Bone. Journal of the American Academy of Orthopaedic Surgeons. 2013; 21(2): 118-126. doi: 10.5435/JAAOS-21-02-118. |
| [7] | Chambers TJ, Fuller K, McSheehy PMJ, Pringle JAS. The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. The Journal of Pathology. 1985; 145(4): 297-305. doi: 10.1002/path.1711450403. |
| [8] | Drake FH, Dodds RA, James IE, et al. Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts. Journal of Biological Chemistry. 1996; 271(21): 12511-12516. doi: 10.1074/jbc.271.21.12511. |
| [9] | Joyner CJ, Quinn JM, Triffitt JT, Owen ME, Athanasou NA. Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone and Mineral. 1992; 16(1): 37-48. doi: 10.1016/0169-6009(92)90820-4. |
| [10] | Lau Y, Sabokbar A, Gibbons C, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Human Pathology. 2005; 36(9): 945-954. doi: 10.1016/j.humpath.2005.07.005. |
| [11] | Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987; 69(1): 106-114. |
| [12] | Knochentumoren A. Local Recurrence of Giant Cell Tumor of Bone After Intralesional Treatment with and without Adjuvant Therapy: The Journal of Bone and Joint Surgery-American Volume. 2008; 90(5): 1060-1067. doi: 10.2106/JBJS.D.02771. |
| [13] | Sklavenitis-Pistofidis R, Getz G, Ghobrial I. Single-cell RNA sequencing: one step closer to the clinic. Nat Med. 2021; 27(3): 375-376. doi: 10.1038/s41591-021-01276-y. |
| [14] | Chen X, Miragaia RJ, Natarajan KN, Teichmann SA. A rapid and robust method for Single-cell chromatin accessibility profiling. Nat Commun. 2018; 9(1): 5345. doi: 10.1038/s41467-018-07771-0. |
| [15] | Ramsköld D, Luo S, Wang YC, et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012; 30(8): 777-782. doi: 10.1038/nbt.2282. |
| [16] | Yan L, Yang M, Guo H, et al. Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013; 20(9): 1131-1139. doi: 10.1038/nsmb.2660. |
| [17] | Mardis ER. The impact of next-generation sequencing technology on genetics. Trends in Genetics. 2008; 24(3): 133-141. doi: 10.1016/j.tig.2007.12.007. |
| [18] | Van De Sande B, Lee JS, Mutasa-Gottgens E, et al. Applications of single-cell RNA sequencing in drug discovery and development. Nat Rev Drug Discov. 2023; 22(6): 496-520. doi: 10.1038/s41573-023-00688-4. |
| [19] | Guo J, Grow EJ, Mlcochova H, et al. The adult human testis transcriptional cell atlas. Cell Res. 2018; 28(12): 1141-1157. doi: 10.1038/s41422-018-0099-2. |
| [20] | Zhong S, Zhang S, Fan X, et al. A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex. Nature. 2018; 555(7697): 524-528. doi: 10.1038/nature25980. |
| [21] | Han X, Chen H, Huang D, et al. Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing. Genome Biol. 2018; 19(1): 47. doi: 10.1186/s13059-018-1426-0. |
| [22] | Kim C, Gao R, Sei E, et al. Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing. Cell. 2018; 173(4): 879-893.e13. doi: 10.1016/j.cell.2018.03.041. |
| [23] | Ho DWH, Tsui YM, Chan LK, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021; 12(1): 3684. doi: 10.1038/s41467-021-24010-1. |
| [24] | Buenrostro JD, Wu B, Litzenburger UM, et al. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature. 2015; 523(7561): 486-490. doi: 10.1038/nature14590. |
| [25] | Chen H, Lareau C, Andreani T, et al. Assessment of computational methods for the analysis of single-cell ATAC-seq data. Genome Biol. 2019; 20(1): 241. doi: 10.1186/s13059-019-1854-5. |
| [26] | Lim B, Lin Y, Navin N. Advancing Cancer Research and Medicine with Single-Cell Genomics. Cancer Cell. 2020; 37(4): 456-470. doi: 10.1016/j.ccell.2020.03.008. |
| [27] | Hedlund E, Deng Q. Single-cell RNA sequencing: Technical advancements and biological applications. Molecular Aspects of Medicine. 2018; 59: 36-46. doi: 10.1016/j.mam.2017.07.003. |
| [28] | Feng W, He M, Jiang X, et al. Single-Cell RNA Sequencing Reveals the Migration of Osteoclasts in Giant Cell Tumor of Bone. Front Oncol. 2021; 11: 715552. doi: 10.3389/fonc.2021.715552. |
| [29] | Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discovery. 2022; 12(1): 31-46. doi: 10.1158/2159-8290.CD-21-1059. |
| [30] | Lee HO, Park WY. Single-cell RNA-Seq unveils tumor microenvironment. BMB Rep. 2017; 50(6): 283-284. doi: 10.5483/BMBRep.2017.50.6.086. |
| [31] | Kashima Y, Togashi Y, Fukuoka S, et al. Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens. Sci Rep. 2021; 11(1): 341. doi: 10.1038/s41598-020-79385-w. |
| [32] | Yang M, Wang F, Lu G, Cheng M, Zhao W, Zou C. Single-cell transcriptome analysis reveals T-cell exhaustion in denosumab-treated giant cell tumor of bone. Front Immunol. 2022; 13: 934078. doi: 10.3389/fimmu.2022.934078. |
| [33] | Feleke M, Feng W, Song D, et al. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma. Exp Biol Med (Maywood). 2022; 247(14): 1214-1227. doi: 10.1177/15353702221088238. |
| [34] | Hong G, Kuek V, Shi J, et al. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis. Journal Cellular Physiology. 2018; 233(11): 8526-8537. doi: 10.1002/jcp.26792. |
| [35] | Luo BH, Xiong F, Wang JP, et al. Epidermal Growth Factor-Like Domain-Containing Protein 7 (EGFL7) Enhances EGF Receptor−AKT Signaling, Epithelial−Mesenchymal Transition, and Metastasis of Gastric Cancer Cells. Andl CD, ed. PLoS ONE. 2014; 9(6): e99922. doi: 10.1371/journal.pone.0099922. |
| [36] | Liu Y, Huang N, Liao S, et al. Current research progress in targeted anti-angiogenesis therapy for osteosarcoma. Cell Proliferation. 2021; 54(9): e13102. doi: 10.1111/cpr.13102. |
| [37] | Zheng MH, Xu J, Robbins P, et al. Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol. 2000; 31(7): 804-812. doi: 10.1053/hupa.2000.8441. |
| [38] | Wherry EJ. T cell exhaustion. Nat Immunol. 2011; 12(6): 492-499. doi: 10.1038/ni.2035. |
| [39] | Huntington ND, Cursons J, Rautela J. The cancer–natural killer cell immunity cycle. Nat Rev Cancer. 2020; 20(8): 437-454. doi: 10.1038/s41568-020-0272-z. |
| [40] | Hashimoto K, Suzuki AM, Dos Santos A, et al. CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors. Genome Res. 2015; 25(12): 1812-1824. doi: 10.1101/gr.191031.115. |
| [41] | Wang Y, Liu B, Min Q, et al. Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression. Cell Discov. 2023; 9(1): 96. doi: 10.1038/s41421-023-00591-7. |
APA Style
Liu, Y., Ye, D. (2024). Research Progress of Single-Cell Sequencing Technology in Giant Cell Tumor of Bone. Cancer Research Journal, 12(1), 5-9. https://doi.org/10.11648/j.crj.20241201.12
ACS Style
Liu, Y.; Ye, D. Research Progress of Single-Cell Sequencing Technology in Giant Cell Tumor of Bone. Cancer Res. J. 2024, 12(1), 5-9. doi: 10.11648/j.crj.20241201.12
AMA Style
Liu Y, Ye D. Research Progress of Single-Cell Sequencing Technology in Giant Cell Tumor of Bone. Cancer Res J. 2024;12(1):5-9. doi: 10.11648/j.crj.20241201.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.crj.20241201.12,
author = {Yiming Liu and Dongping Ye},
title = {Research Progress of Single-Cell Sequencing Technology in Giant Cell Tumor of Bone},
journal = {Cancer Research Journal},
volume = {12},
number = {1},
pages = {5-9},
doi = {10.11648/j.crj.20241201.12},
url = {https://doi.org/10.11648/j.crj.20241201.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20241201.12},
abstract = {Giant Cell Tumor of Bone (GCTB) is a common intermediate tumor, and the specific molecular mechanisms of this disease have not been fully elucidated. It exhibits strong heterogeneity in terms of targets, regulatory mechanisms, cell types, states, and subset distributions in the immune microenvironment. Traditional collective-level analyses cannot accurately reveal these differences. Single-cell sequencing technology is a technique that sequences the genome, transcriptome, and epigenome of diseases at the single-cell level. Single-cell sequencing can utilize a higher pixel resolution to reveal characteristic states of different cell subpopulations, contributing to broadening new perspectives for the study of GCTB heterogeneity. It holds significant value for the precise diagnosis of GCTB, identification of potential immunotherapy targets, and prognosis assessment. This study primarily reviews research related to GCTB, single-cell high-throughput sequencing technology, GCTB immune microenvironment, GCTB heterogeneity, and the construction of GCTB cell maps. It aims to provide theoretical reference for research on single-cell sequencing technology in GCTB and offers a theoretical basis for in-depth exploration of the mechanisms and treatment of GCTB.
},
year = {2024}
}
TY - JOUR T1 - Research Progress of Single-Cell Sequencing Technology in Giant Cell Tumor of Bone AU - Yiming Liu AU - Dongping Ye Y1 - 2024/01/18 PY - 2024 N1 - https://doi.org/10.11648/j.crj.20241201.12 DO - 10.11648/j.crj.20241201.12 T2 - Cancer Research Journal JF - Cancer Research Journal JO - Cancer Research Journal SP - 5 EP - 9 PB - Science Publishing Group SN - 2330-8214 UR - https://doi.org/10.11648/j.crj.20241201.12 AB - Giant Cell Tumor of Bone (GCTB) is a common intermediate tumor, and the specific molecular mechanisms of this disease have not been fully elucidated. It exhibits strong heterogeneity in terms of targets, regulatory mechanisms, cell types, states, and subset distributions in the immune microenvironment. Traditional collective-level analyses cannot accurately reveal these differences. Single-cell sequencing technology is a technique that sequences the genome, transcriptome, and epigenome of diseases at the single-cell level. Single-cell sequencing can utilize a higher pixel resolution to reveal characteristic states of different cell subpopulations, contributing to broadening new perspectives for the study of GCTB heterogeneity. It holds significant value for the precise diagnosis of GCTB, identification of potential immunotherapy targets, and prognosis assessment. This study primarily reviews research related to GCTB, single-cell high-throughput sequencing technology, GCTB immune microenvironment, GCTB heterogeneity, and the construction of GCTB cell maps. It aims to provide theoretical reference for research on single-cell sequencing technology in GCTB and offers a theoretical basis for in-depth exploration of the mechanisms and treatment of GCTB. VL - 12 IS - 1 ER -
Guangzhou Red Cross Hospital, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China
Guangzhou Red Cross Hospital, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China
